- Filed
- Mar 31, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 1, 2025 | 13.67M sh |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 12.26M sh |
| Capex | FY 2024 · Dec 31, 2023 | $772.25K |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | $2.1M |
| Stockholders Equity | FY 2024 · Dec 31, 2023 | $17.75M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $1.73M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $3.35M |
| Current Assets | FY 2024 · Dec 31, 2023 | $4.45M |
| Total Assets | FY 2024 · Dec 31, 2023 | $23.89M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | $0.09 |
| Eps Basic | FY 2024 · Dec 31, 2023 | $0.09 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $630.13K |
| Net Income restated | FY 2024 · Dec 31, 2023 | $1.16M |
| Operating Income | FY 2024 · Dec 31, 2023 | $1.01M |
| Gross Profit | FY 2024 · Dec 31, 2023 | $3.97M |
| Cost Of Revenue | FY 2024 · Dec 31, 2023 | $9.69M |
| Revenue | FY 2024 · Dec 31, 2023 | $13.66M |